oculocutaneous albinism type 6
ORPHA: 3700971 Treatment Available
Overview
disease
Available Treatments (1)
| Drug | Form | Status | Countries | Lead Time |
|---|---|---|---|---|
| Nitisinone Orphan | Oral capsule, 2mg, 5mg, 10mg, 20mg; Oral suspension, 4mg/mL | FDA Approved | 7 | 21d |
Clinical Presentation
Signs and symptoms associated with oculocutaneous albinism type 6, sourced from HPO and Orphanet clinical annotations.
PhotophobiaNystagmusAbnormal fundus morphologyReduced visual acuityAbnormal iris pigmentationAplasia/Hypoplasia of the maculaAbnormal foveal morphology on macular OCT
Classification & Codes
Orphanet Code
ORPHA:370097oculocutaneous albinism type 6
| Orphanet | ORPHA:370097 |
| Treatments | 1 drug(s) |
| Symptoms on record | 7 signs |
| Status | published |
Treatment Summary
Factual Authority
Last Updated3/20/2026
Clinical DataHPO · Orphanet
Drug DataFDA · EMA · CDSCO